Co-occurring depression & physical disorders: Need for an adequate response from the health care system

Indian Journal of Medical Research

Volumn 122, Issue 4, 2005, Pages 273-276

  Saxena, Shekhar ^a   Bertolote, Jose Manoel ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DYSTHYMIA; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LOWEST INCOME GROUP; MENTAL HEALTH CARE; MORTALITY; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICAL DISEASE; PREVALENCE; PRIMARY HEALTH CARE; PROGNOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RURAL AREA; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

DELIVERY OF HEALTH CARE; DEPRESSION; HUMANS;

EID: 30744452235     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Fukunishi I, Matsumoto T, Negishi M, Hayashi M, Hosaka T, Moriya H. Somatic complaints associated with depressive symptoms in HIV-positive patients. Psychother Psychosom 1997; 66: 248-51.
2. Dew MA, Becker JT, Sanchez J, Caldararo R, Lopez OL, Wess J, et al Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med 1997; 27: 395-406
3. Bertolote JM, Tarsitani L, Paula-Ramos FL. La comorbilidad de la depresión y otras enfermedades: un antiguo problema sanitario, us nuevo programa de la OMS. Átopos 2003; 1: 56-60.
4. Chandra PS, Desai G, Ranjan S. HIV & psychiatric disorders. Indian J Med Res 2005; 121: 451-67.
5. Janca A. Rethinking somatoform disorders. Curr Opin Psychiatr 2005; 18: 65-71.
6. Kendler KS, Hettema JM, Butera F, Gardner CO, Prescott CA. Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry 2003; 60: 789-96.
7. World Health Organization. The World Health Report 2001: Mental Health New understanding, new hope. Geneva: World Health Organization, 2001.
8. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med 1999; 61: 6-17.
9. Koenig HG, George LK, Peterson BL, Pieper CF. Depression in medically ill hospitalized older adults; prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiarty 1997; 154: 1376-83.
10. Unutzer J, Patrick DL, Diehr P, Simon G, Grembowski D, Katon W. Quality adjusted life years in older adults with depressive symptoms and chronic medical disorders. Int Psychogeriatr 2000; 12: 15-33.
11. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatemnt: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7.
12. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160: 3278-85
13. World Health Organization. Innovative care for chronic conditions (Doc.: WHO/MNC/CCH/01.01). Geneva: World Health Organization, 2001.
14. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization, 2003.
15. http/www.wfmh.org/wmhday2005.htm accessed on 27.07.05.
16. World Health Organization, Mental health atlas, 2005. Geneva: World Health Organization.